VENTRUS BIOSCIENCES INC — Form D/A
VENTRUS BIOSCIENCES INC of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2010-04-26. The offering totals $4.5M, of which $2.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-04-26
- Form: D/A
- Accession: 0001426800-10-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $4.5M
- Amount sold: $2.7M
- Remaining: $1.8M
- Minimum investment: $25K
- Investors: 44
- Date of first sale: 2010-02-26
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-114599
Issuer
- Name: VENTRUS BIOSCIENCES INC
- CIK: 0001426800
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2005
- Address: 787 7TH AVENUE, NEW YORK, NY, 10019
- Phone: (212) 554-4388
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Joseph Felder | Director | New York, NY |
| Thom Rowland | Director | New York, NY |
| Thom Rowland | Executive Officer | New York, NY |
Other filings by this issuer (2)
More